Transgene Biotek Limited (BOM:526139)
India flag India · Delayed Price · Currency is INR
2.460
-0.170 (-6.46%)
At close: Jan 20, 2026

Transgene Biotek Company Description

Transgene Biotek Limited, a biotechnology company, provides research and development services for bulk drugs in India.

It offers a portfolio of oncology drugs, oral drug delivery, and biogenerics. The company provides TrabiDHA for use in health food, baby food/formula, health supplement, and chicken and animal feed markets; Tacrolimus, a drug that suppresses the immune system and is used to prevent rejection of transplanted organs; and Orlistat (tetrahydrolipstatin), a lipase inhibitor that blocks about one-third of intestinal fat absorption.

The company was incorporated in 1990 and is based in Sangareddy, India.

Transgene Biotek Limited
CountryIndia
Founded1990
IndustryBiological Products, Except Diagnostic Substances
CEOKoteswara Kanuru

Contact Details

Address:
Plot No. 69 & 70
Sangareddy, 502325
India
Phone91 40 6558 9499
Websitetransgenebiotek.com

Stock Details

Ticker Symbol526139
ExchangeBombay Stock Exchange
Fiscal YearApril - March
Reporting CurrencyINR
SIC Code2836

Key Executives

NamePosition
Koteswara KanuruChief Executive Officer
Chowdari PrasadChief Financial Officer